Impact of M-health Based Intervention on Adherence to Healthy Physical Activity After Stroke.
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03507894 |
|
Recruitment Status : Unknown
Verified January 2019 by Montserrat Grau-Pellicer, Consorci Sanitari de Terrassa.
Recruitment status was: Active, not recruiting
First Posted : April 25, 2018
Last Update Posted : January 31, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Stroke | Behavioral: Multimodal Exercise Rehabilitation Program |
| Study Type : | Observational |
| Estimated Enrollment : | 58 participants |
| Observational Model: | Other |
| Time Perspective: | Prospective |
| Official Title: | Impact of M-health Based Intervention on Adherence to Healthy Physical Activity After Stroke. Randomized Study |
| Actual Study Start Date : | April 3, 2018 |
| Actual Primary Completion Date : | December 28, 2018 |
| Estimated Study Completion Date : | January 26, 2019 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
m-health stroke rehabilitation
8-week multimodal exercise rehabilitation program (MERP) based on aerobic exercise, task oriented activities, balance and stretching exercises complemented with a mobile app technology
|
Behavioral: Multimodal Exercise Rehabilitation Program
Rehabilitation program based on aerobic exercise, task oriented activities, balance and stretching exercises complemented with a mobile app technology |
- Adherence [ Time Frame: 8 weeks ]Adherence will be monitored with an app that will record activity time (walking time and distance)
- Gait speed [ Time Frame: 8 weeks ]Gait speed will be measured with the Ten Meter Walking Test (10MWT). Participants will be given a 2-meter warm-up distance for walking, preceding the 10-meter distance, and 2 meters beyond the 10 meters. The time that takes to walk 10 meters at a comfortable pace and at their maximum speed will be registered in meters/second
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Diagnosis of ischemic or hemorrhagic stroke
- age ≥18;
- Functional Ambulation Classification (FAC) ≥3
- Barthel Index ≥45
Exclusion Criteria:
- Cognitive impairment (Mini Mental State Examination ≤24)
- Unstable cardiovascular disease (acute heart failure, recent myocardial infarction, unstable angina and uncontrolled arrhythmias)
- Alcohol or other toxic substances abuse
- Decompensated psychiatric disorders that prevented from following a group session
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03507894
| Spain | |
| Consorci Sanitari de Terrassa | |
| Terrassa, Barcelona, Spain, 08232 | |
| Principal Investigator: | Montserrat Grau-Pellicer, PhD | Consorci Sanitari de Terrassa |
| Responsible Party: | Montserrat Grau-Pellicer, Principal Investigator, Consorci Sanitari de Terrassa |
| ClinicalTrials.gov Identifier: | NCT03507894 |
| Other Study ID Numbers: |
ConsorciST |
| First Posted: | April 25, 2018 Key Record Dates |
| Last Update Posted: | January 31, 2019 |
| Last Verified: | January 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
rehabilitation exercise stroke adherence |
|
Stroke Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Vascular Diseases Cardiovascular Diseases |

